5th Annual Induced Proximity-Based Drug Discovery Summit

DISCOVER: How industry leaders are unlocking novel degrader and non-degrader proximity-based MoAs including RipTACs, DUBTACS, tPRIME’s, RIBOTACs and beyond, leveraging AI, advanced screening, and chemical biology to drive safer and more effective therapies BUILD: Your knowledge of drug design, selectivity, and functional validation. Explore how experts are integrating multi-modal assays, structure-based drug design, and chemical optimization to enhance drug efficacy, and improve translational success ENGAGE: With leading biopharma experts from Genentech, Novartis, Astellas, Plexium, Halda, and more to forge collaborations, share insights, and accelerate therapeutic development